Bonini Matteo, Palange Paolo
Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Viale dell'Universita', 37, 00185 Rome, Italy.
Asthma Res Pract. 2015 Jul 2;1:2. doi: 10.1186/s40733-015-0004-4. eCollection 2015.
The acute airway narrowing that occurs as a result of exercise is defined exercise-induced bronchoconstriction (EIB). Most recent guidelines recommend distinguishing EIB with underlying clinical asthma (EIB) from the occurrence of bronchial obstruction in subjects without other symptoms and signs of asthma (EIBw). EIB has been in fact reported in up to 90 % of asthmatic patients, reflecting the level of disease control, but it may develop even in subjects without clinical asthma, particularly in children, athletes, patients with atopy or rhinitis and following respiratory infections. Both EIB and EIBw have peculiar pathogenic mechanisms, diagnostic criteria and responses to treatment and prevention. The use of biomarkers, proteomic approaches and innovative technological procedures will hopefully contribute to better define peculiar phenotypes and to clarify the role of EIB as risk factor for the development of asthma, as well as an occupational disease.
运动导致的急性气道狭窄被定义为运动诱发的支气管收缩(EIB)。最新指南建议将伴有潜在临床哮喘的运动诱发的支气管收缩(EIB)与无其他哮喘症状和体征的受试者中发生的支气管阻塞(EIBw)区分开来。事实上,高达90%的哮喘患者报告有EIB,这反映了疾病控制水平,但EIB甚至可能在无临床哮喘的受试者中发生,尤其是儿童、运动员、特应性或鼻炎患者以及呼吸道感染后。EIB和EIBw都有独特的致病机制、诊断标准以及对治疗和预防的反应。生物标志物、蛋白质组学方法和创新技术程序的应用有望有助于更好地定义特殊表型,并阐明EIB作为哮喘发展的危险因素以及职业病的作用。